Intuitive Surgical, Inc. (ISRG)
ISRG Stock Falls Despite Q1 Earnings Beat, Gross Margin Contracts
ISRG's first-quarter results reflect a healthy demand for procedures on higher system utilization. However, tariffs lead to a decline in the gross margin outlook.
Intuitive Surgical, Inc. (ISRG) Q1 2025 Earnings Call Transcript
Intuitive Surgical, Inc. (NASDAQ:ISRG ) Q1 2025 Earnings Conference Call April 22, 2025 4:30 AM ET Company Participants Dan Connally - Head of IR Gary Guthart - CEO David Rosa - President Jamie Samath - CFO Daniel Oh - Senior Medical Officer Conference Call Participants Travis Steed - Bank of America Securities Larry Biegelsen - Wells Fargo Robbie Marcus - JPMorgan Rick Wise - Stifel Adam Maeder - Piper Sandler Ryan Zimmerman - BTIG David Roman - Goldman Sachs Operator Thank you for standing by, and welcome to the Intuitive Surgical, Inc.'s First Quarter 2025 Earnings Release. [Operator Instructions] As a reminder, today's program is being recorded.
Intuitive Surgical (ISRG) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Intuitive Surgical (ISRG) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Intuitive Surgical, Inc. (ISRG) Q1 Earnings and Revenues Beat Estimates
Intuitive Surgical, Inc. (ISRG) came out with quarterly earnings of $1.81 per share, beating the Zacks Consensus Estimate of $1.71 per share. This compares to earnings of $1.50 per share a year ago.
Intuitive Surgical beats quarterly results, raises tariff concerns
Intuitive Surgical raised concerns on Tuesday about the potential impact of tariffs on its annual results, despite exceeding Wall Street's first-quarter profit and revenue estimates.
ISRG Q1 Earnings Coming Up: Time to Buy, Sell or Hold the Stock?
Intuitive Surgical's first-quarter results are likely to reflect solid performance in the company???s Instruments & Accessories segment.
Is It Worth Investing in Intuitive Surgical (ISRG) Based on Wall Street's Bullish Views?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
Gear Up for Intuitive Surgical (ISRG) Q1 Earnings: Wall Street Estimates for Key Metrics
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Intuitive Surgical (ISRG), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2025.
Intuitive Surgical, Inc. (ISRG) Reports Next Week: Wall Street Expects Earnings Growth
Intuitive Surgical (ISRG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Intuitive Surgical, Inc. (ISRG) Stock Falls Amid Market Uptick: What Investors Need to Know
Intuitive Surgical, Inc. (ISRG) concluded the recent trading session at $490.13, signifying a -0.7% move from its prior day's close.
Intuitive Surgical Shares May Rise as FDA Clears SureForm 45 Stapler
ISRG secures FDA clearance for the first stapler designed for single-port robotic surgery, advancing minimally invasive procedures and enhancing surgical precision.
